The Association of Transient Ischemic Attack Symptoms With Memory Impairment Among Elderly Participants of the Third US National Health and Nutrition Examination Survey

Abstract

Background and Purpose: Stroke is a well-known risk factor for vascular dementia. However, the association of transient ischemic attacks with cognitive impairment is less well-established.

Methods: Records from Third National Health and Nutrition Examination Survey were abstracted for demographic and medical information for participants with an age !60 years who reported being free of stroke. Five self-reported symptoms (weakness, numbness, loss of vision, inability to speak, and severe dizziness) were used as surrogates representing transient ischemic attacks. Information on conventional risk factors for vascular dementia was also obtained. Multivariable logistic regression was used to examine risk factors for memory impairment. Results: 4617 participants were included with a sample-weighted prevalence of memory impairment of 6.6% (1417 participants). The final multivariable analysis revealed a significant association between transient weakness and memory impairment (odds ratio 1.52, 95% CI 1.11-2.07). The other 4 transient ischemic attacks symptoms were not significantly associated with memory impairment in the final model. Systolic blood pressure >140 was most strongly associated with prevalent memory impairment (odds ratio, 9.78, 95% CI 1.49-64.3). Other associated risk factors included non-white race, male gender, age, education ≤12 years, and history of any alcohol use.

Conclusion: Among transient ischemic attacks symptoms, self-reported weakness in the face, arm, or leg was significantly associated with memory impairment. This study indicates that transient ischemic attacks symptoms are, even in the absence of stroke, associated with memory impairment. Aggressive risk factor modification in patients with TIA symptoms may be warranted to prevent potential future memory loss.

Keywords

transient ischemic attack memory impairment NHANES III

Get full access to this article

View all access options for this article.

References

Association AP Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. 4th ed. Washington, D.C: American Psychiatric Association; 2000.

Hebert LE , Scherr PA , Bienias JL , Bennett DA , Evans DA Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119-1122.

Plassman BL , Langa KM , Fisher GG , et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29:125-132.

Zhu CW , Scarmeas N. , Torgan R. , et al. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology. 2006;67:998-1005.

Langa KM , Foster NL , Larson EB Mixed dementia: emerging concepts and therapeutic implications. JAMA. 2004;292:2901-2908.

Knopman DS , Rocca WA , Cha RH , Edland SD , Kokmen E. Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol. 2003;60:85-90.

Knopman DS Dementia and cerebrovascular disease. Mayo Clin Proc. 2006;81:223-230.

Mielke MM , Rosenberg PB , Tschanz J. , et al. Vascular factors predict rate of progression in Alzheimer disease . Neurology. 2007;69:1850-1858.

Barba R. , Martinez-Espinosa S. , Rodriguez-Garcia E. , Pondal M. , Vivancos J. , Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke. 2000;31: 1494-1501.

10.

Desmond DW , Moroney JT , Sano M. , Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study . Stroke. 2002;33:2254-2260.

11.

Qiu C. , Winblad B. , Fratiglioni L. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population. Neurol Res. 2006;28: 650-656.

12.

Bos MJ , van Rijn MJ , Witteman JC , Hofman A. , Koudstaal PJ , Breteler MM Incidence and prognosis of transient neurological attacks. JAMA. 2007;298: 2877-2885.

13.

Meyer JS , Rauch GM , Crawford K. , et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatr. 1999;14: 1050-1061.

14.

Popovic IM , Seric V. , Demarin V. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. J Neurol Sci. 2007;257:185-193.

15.

National Health and Nutrition Examination Survey III. Center for Disease Control, 1996. Available at www.cdc.gov.in. Accessed 2006.

16.

Perkins AJ , Hendrie HC , Callahan CM , et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 1999;150:37-44.

17.

Aronowski J. , Strong R. , Grotta JC Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab. 1997;17:1048-1056.

18.

Bisschops RH , Kappelle LJ , Mali WP , van der Grond J. Hemodynamic and metabolic changes in transient ischemic attack patients: a magnetic resonance angiography and (1)H-magnetic resonance spectroscopy study performed within 3 days of onset of a transient ischemic attack. Stroke. 2002;33:110-115.

19.

Karanjia PN , Nelson JJ , Lefkowitz DS , et al. Validation of the ACAS TIA/stroke algorithm. Neurology. 1997;48: 346-351.

20.

Janssen I. , Katzmarzyk PT , Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379-384.

21.

Gorelick PB Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35(11 Suppl 1): 2620-2622.

22.

Elias MF , Wolf PA , D'Agostino RB , Cobb J. , White LR Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993 ;138:353-364.

23.

Hebert R. , Lindsay J. , Verreault R. , Rockwood K. , Hill G. , Dubois MF Vascular dementia:incidence and risk factors in the Canadian study of health and aging. Stroke. 2000;31:1487-1493.

24.

Kilander L. , Nyman H. , Boberg M. , Hansson L. , Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998;31: 780-786.

25.

Skoog I. , Lernfelt B. , Landahl S. , et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.

26.

Kuller LH , Lopez OL , Jagust WJ , et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology. 2005;64:1548-1552.

27.

Evans DA , Hebert LE , Beckett LA , et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol. 1997;54:1399-1405.

28.

Tyas SL , White LR , Petrovitch H. , et al. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiol Aging. 2003;24:589-596.

29.

Deng J. , Zhou DH , Li J. , Wang YJ , Gao C. , Chen M. A 2-year follow-up study of alcohol consumption and risk of dementia. Clin Neurol Neurosurg. 2006;108:378-383.

30.

Borson S. , Scanlan JM , Chen P. , Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample . J Am Geriatr Soc. 2003;51:1451-1454.

31.

Buschke H. , Kuslansky G. , Katz M. , et al. Screening for dementia with the Memory Impairment Screen. Neurology. 1999;52:231-238.

32.

Flemming KD , Brown, RD Jr , Petty GW , Huston J., 3rd , Kallmes DF , Piepgras DG Evaluation and management of transient ischemic attack and minor cerebral infarction. Mayo Clin Proc. 2004;79:1071-1086.

33.

Krol AL , Coutts SB , Simon JE , Hill MD , Sohn CH , Demchuk AM Perfusion MRI abnormalities in speech or motor transient ischemic attack patients . Stroke. 2005;36:2487-2489.